ES2151502T3 - Complejos quelato y procedimientos para su obtencion. - Google Patents

Complejos quelato y procedimientos para su obtencion.

Info

Publication number
ES2151502T3
ES2151502T3 ES93810100T ES93810100T ES2151502T3 ES 2151502 T3 ES2151502 T3 ES 2151502T3 ES 93810100 T ES93810100 T ES 93810100T ES 93810100 T ES93810100 T ES 93810100T ES 2151502 T3 ES2151502 T3 ES 2151502T3
Authority
ES
Spain
Prior art keywords
complexes
chelato
procedures
obtaining
rutenio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93810100T
Other languages
English (en)
Inventor
Hans Georg Dr Capraro
Marcus Dr Baumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2151502T3 publication Critical patent/ES2151502T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06—Aluminium compounds
    • C07F5/069—Aluminium compounds without C-aluminium linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds
    • C07F15/0053—Ruthenium compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0836—Compounds with one or more Si-OH or Si-O-metal linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyethers (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBEN COMPLEJOS QUELATO MULA I, DONDE M COMO ATOMO CENTRAL ES ALUMINIO, GALIO, INDIO, CINC, RUTENIO O DE FORMA PREFERENTE GERMANIO Y DONDE LOS SIMBOLOS RESTANTES SON DEFINIDOS COMO EN LA SOLICITUD DE PATENTE 1. LOS COMPLEJOS PUEDEN SER UTILIZADOS ENTRE OTRAS APLICACIONES PARA LA QUIMIOTERAPIA FOTODINAMICA DE TUMORES.
ES93810100T 1992-02-27 1993-02-18 Complejos quelato y procedimientos para su obtencion. Expired - Lifetime ES2151502T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH60092 1992-02-27

Publications (1)

Publication Number Publication Date
ES2151502T3 true ES2151502T3 (es) 2001-01-01

Family

ID=4190744

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93810100T Expired - Lifetime ES2151502T3 (es) 1992-02-27 1993-02-18 Complejos quelato y procedimientos para su obtencion.

Country Status (22)

Country Link
US (3) US5358940A (es)
EP (1) EP0558449B1 (es)
JP (1) JPH0656839A (es)
KR (1) KR100270284B1 (es)
CN (1) CN1044476C (es)
AT (1) ATE196143T1 (es)
AU (1) AU662800B2 (es)
CA (1) CA2090772A1 (es)
DE (1) DE59310096D1 (es)
DK (1) DK0558449T3 (es)
ES (1) ES2151502T3 (es)
FI (1) FI930831A7 (es)
GR (1) GR3034887T3 (es)
HU (1) HUT64075A (es)
IL (1) IL104874A (es)
MX (1) MX9301083A (es)
NO (1) NO930719L (es)
NZ (1) NZ247000A (es)
PT (1) PT558449E (es)
SG (1) SG49615A1 (es)
TW (1) TW235298B (es)
ZA (1) ZA931382B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484778C1 (en) * 1990-07-17 2001-05-08 Univ Cleveland Hospitals Phthalocynine photosensitizers for photodynamic therapy and methods for their use
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
GB9123814D0 (en) * 1991-11-08 1992-01-02 Johnson Matthey Plc Photosensitizers
TW235298B (es) * 1992-02-27 1994-12-01 Ciba Geigy
GB9405970D0 (en) * 1994-03-25 1994-05-11 Secr Defence Substituted phthalocyanines
RU2106146C1 (ru) * 1995-07-17 1998-03-10 Институт элементоорганических соединений РАН Средство для подавления опухолевого роста
US5763602A (en) * 1996-10-01 1998-06-09 Li; Ying-Syi Methods of syntheses of phthalocyanine compounds
US5872248A (en) * 1997-03-28 1999-02-16 Case Western Reserve University Methods for inserting silicon into phthalocyanines and naphthalocyanines
IL121440A0 (en) 1997-07-31 1998-01-04 Yeda Res & Dev The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
US6645928B1 (en) * 1999-03-05 2003-11-11 Case Western Reserve University Hydrophobic liquid photobleaches
US8211883B2 (en) * 2004-04-01 2012-07-03 Case Western Reserve University Topical delivery of phthalocyanines
US7153956B2 (en) * 2004-08-09 2006-12-26 Silverbrook Research Pty Ltd Cyanine dye having multifunctional peripheral groups
JP2010163473A (ja) * 2009-01-13 2010-07-29 Konica Minolta Business Technologies Inc インクジェット記録用シアンインク
US8440641B2 (en) * 2009-03-20 2013-05-14 Case Western Reserve University Phthalocyanine salt formulations
CA2907356C (en) 2013-03-15 2022-07-12 Sherri Ann MCFARLAND Metal-based coordination complexes as photodynamic compounds and their use
WO2019188118A1 (ja) * 2018-03-29 2019-10-03 パナソニックＩｐマネジメント株式会社 組成物、光電変換素子および撮像装置
JP6767695B2 (ja) 2018-03-29 2020-10-14 パナソニックＩｐマネジメント株式会社 組成物、近赤外光電変換素子および撮像装置
WO2024225218A1 (ja) * 2023-04-25 2024-10-31 キヤノン株式会社 一重項酸素の発生方法、一重項酸素の発生システム、一重項酸素の発生キット、及び一重項酸素発生剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3094535A (en) * 1961-01-03 1963-06-18 Malcolm E Kenney Germanium phthalocyanines
US3094536A (en) * 1961-01-03 1963-06-18 Malcolm E Kenney Silicon phthalocyanines
CA1337194C (en) * 1988-04-07 1995-10-03 Koichi Kamijima Tetraazaporphin, process for producing the same, as well as optical recording media using the same and production processes thereof
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
DE3829851A1 (de) * 1988-09-02 1990-03-08 Basf Ag Tetraazaporphyrine sowie strahlungsempfindliche beschichtungsfilme
US5457195A (en) * 1989-12-21 1995-10-10 Board Of Regents, The University Of Texas System Sapphyrin derivatives and conjugates
IL97681A (en) * 1990-04-03 1996-01-31 Ciba Geigy Ag Parenterally administrable liposome formulation comprising synthetic lipids
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
EP0529002B1 (en) * 1990-05-15 2001-10-04 Hyperion, Inc. Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes
WO1991018007A1 (en) * 1990-05-15 1991-11-28 Diatron Corporation Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents
US5166197A (en) * 1990-07-17 1992-11-24 Kenney Malcolm E Phthalocyanine photosensitizers for photodynamic therapy
US5260435A (en) * 1990-07-23 1993-11-09 Nippon Oil And Fats Co., Ltd. Derivative of naphthalocyanine containing perfluoroalkyl group, process for preparing the same and optical recording medium
GB9123814D0 (en) * 1991-11-08 1992-01-02 Johnson Matthey Plc Photosensitizers
TW235298B (es) * 1992-02-27 1994-12-01 Ciba Geigy

Also Published As

Publication number Publication date
CN1075966A (zh) 1993-09-08
DE59310096D1 (de) 2000-10-12
SG49615A1 (en) 2001-01-16
MX9301083A (es) 1993-09-01
EP0558449A1 (de) 1993-09-01
IL104874A0 (en) 1993-06-10
KR930017912A (ko) 1993-09-20
AU3376893A (en) 1993-09-02
CN1044476C (zh) 1999-08-04
EP0558449B1 (de) 2000-09-06
US5358940A (en) 1994-10-25
AU662800B2 (en) 1995-09-14
ZA931382B (en) 1993-08-31
KR100270284B1 (ko) 2000-10-16
JPH0656839A (ja) 1994-03-01
FI930831A0 (fi) 1993-02-24
NZ247000A (en) 1995-07-26
NO930719L (no) 1993-08-30
PT558449E (pt) 2001-02-28
US5686439A (en) 1997-11-11
NO930719D0 (no) 1993-02-26
DK0558449T3 (da) 2001-01-02
HU9300554D0 (en) 1993-05-28
US5670491A (en) 1997-09-23
ATE196143T1 (de) 2000-09-15
HUT64075A (en) 1993-11-29
GR3034887T3 (en) 2001-02-28
FI930831A7 (fi) 1993-08-28
CA2090772A1 (en) 1993-08-28
IL104874A (en) 1998-06-15
TW235298B (es) 1994-12-01

Similar Documents

Publication Publication Date Title
ES2151502T3 (es) Complejos quelato y procedimientos para su obtencion.
MX9200675A (es) Derivados de 2,4-diaminoquinazolinas para mejorar la actividad antitumoral.
DK0556310T3 (da) Quinazolinderivater til forhøjelse af antitumoraktivitet
BG29132A3 (en) Method of obtaining of cyclohexan derivatives
ATA769376A (de) Boeschungssicherungsanordnung fuer die boeschung von daemmen, gelaendeeinschnitten und dgl.
IT1126452B (it) Testa di estrusione per profilati per infissi e simili,nonche' profilato ottenuto
ES2036809T3 (es) Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas.
SE7613588L (sv) Forfarande for framstellning av 3,4-dihydro-kinazolinderivat
AT359352B (de) Chromquelle fuer das elektroplattieren und ihre herstellung
ES523660A0 (es) Procedimiento para preparar fenoxipiridinas sulfuro-sustituidas teniendo actividad antiviral. desglose de la patente n 514.940.
SE8006294L (sv) 8-aminoalkyl-4-alkylpsoralener
IT7851802A0 (it) Mento per la relativa fabbricazione perfezionamento nelle lampade per illuminazione subacquea e procedi
ES2166900T3 (es) Derivados de ara-c.
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
ES467189A1 (es) Un procedimiento para la preparacion de nuevas pirroloquino-xalinonas y pirrolobenzodiazepinonas
IT1063073B (it) Utensile da taglio e relativo procedimento per aumentare la resistenza all'usura
BG36631A3 (bg) Метод за получаване на сяросъдържащи изохинолинови производни
FI830207L (fi) Pantenolderivat
IT1093259B (it) Composizione per il trattamento,in particolare,della cellulite
FR2319364A1 (fr) Nouvelles diamino-2,4 (p-aminobenzyl)-5 pyrimidines, utiles notamment comme agents antibacteriens
SE8502865D0 (sv) Naphtoxazine, ihre herstellung und verwendung
IT8422224A0 (it) Amminoantrachinoni cis-platino complessi e loro impiego come agenti antitumorali.
FR2358403A1 (fr) Nouveaux 2-imino-1,3-benzodithiolannes utiles notamment comme anti-inflammatoires
TR18913A (tr) S-suebstitueye 5-triflorometil-1,3,4-tiadiazoller,bunlarin,hazirlanisina ait usuller ve bunlarin fungisidler ve ensektisidler olarak kullanilmalari
IT1123064B (it) Procedimento per la produzione di epsilon-caprolattame in particolare da nitrobenzene

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 558449

Country of ref document: ES